Delivery Order SPE2DB20D2104-SPE2DB24FR82F
- Not listed
- This federal contract award is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,041.51 and an ultimate completion date of December 28, 2023. It is a delivery order contract with a firm fixed-price pricing type. The contract was...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a pharmaceutical product called XARELTO 20 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $20,068.96 and an ultimate completion date of March 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of XARELTO 20 MG TABLET 90S. The contract, valued at $5,766.49, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- The federal contract award is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $15,507.66 and is a firm fixed price delivery order, with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,741.67, is a Firm Fixed Price Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of pharmaceutical products, specifically Xarelto 20 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $11,279.38 with a firm fixed price and a completion date of February 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $15,440.17 and a completion date of May 1, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the delivery of XARELTO 20 MG TABLET 90S to the Defense Logistics Agency (DLA). The $32,906.13 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 27, 2024, with a completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product, to the Medical Supply Chain, a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The firm-fixed-price delivery order has a ceiling value of $13,163.48 and an ultimate completion date of May 18, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,366.56 and is a Firm Fixed Price Delivery Order with an ultimate completion date of December 4, 2024. The contract is not designated with any set-aside requirements,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR82FDelivery Order
This federal contract award is for the delivery of pharmaceutical products, specifically XARELTO 20 MG TABLET 90S, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,349.60 and an ultimate completion date of December 29, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded on December 28, 2023, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 12/28/23 |